Pediatric Atopic Dermatitis (AD) Internet Survey
NCT01385527 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2018-07-06
Summary
The purpose of this study is to evaluate whether participation in an Internet-based intervention helps improve atopic dermatitis treatment outcomes.
Conditions
Interventions
- BEHAVIORAL
-
Weekly Internet survey
Parents will complete a weekly online survey about medication use.
- DRUG
-
Topical Triamcinolone
Topical triamcinolone to all affected areas once daily
Sponsors & Collaborators
-
Wake Forest University
lead OTHER
Principal Investigators
-
Steven R Feldman, MD, PhD · Wake Forest University Health Sciences
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 2 Years
- Max Age
- 8 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-06-30
- Primary Completion
- 2014-10-27
- Completion
- 2014-10-27
More Related Trials
-
Systemic Therapies for Pediatric Atopic Dermatitis
NCT01447381 ·Status: UNKNOWN
-
Twice Daily Versus Twice Weekly Soak-and-Seal Baths in Pediatric Atopic Dermatitis
NCT03397979 ·Status: COMPLETED ·Phase: NA
-
A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal
NCT02317276 ·Status: TERMINATED ·Phase: PHASE4
-
Observational Evaluation of Atopic Dermatitis in Pediatric Patients
NCT03687359 ·Status: ACTIVE_NOT_RECRUITING
-
Tacrolimus Versus Hydrocortisone in Atopic Dermatitis
NCT05324618 ·Status: COMPLETED ·Phase: PHASE4
-
Moisturizer to Prevent Atopic Dermatitis
NCT03808532 ·Status: WITHDRAWN ·Phase: PHASE2
-
Texting Atopic Dermatitis Patients to Optimize Learning and EASI Scores
NCT02779426 ·Status: COMPLETED ·Phase: NA
-
To Evaluate the Safety and Efficacy of a New Device in the Management of Mild to Moderate Atopic Dermatitis in Children
NCT00886587 ·Status: COMPLETED ·Phase: NA
-
Effect of Oral Steroids on Skin Outcomes in Atopic Dermatitis
NCT02908698 ·Status: TERMINATED ·Phase: NA
-
Topical Treatment for Atopic Dermatitis
NCT06244212 ·Status: RECRUITING ·Phase: NA
-
Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis
NCT05387707 ·Status: TERMINATED ·Phase: PHASE3
-
A Multicenter Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 Months
NCT02634905 ·Status: TERMINATED ·Phase: NA
-
A Psychoeducational Prevention for the Treatment of Atopic Dermatitis in Youth and Their Families
NCT02067234 ·Status: WITHDRAWN ·Phase: NA
-
An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic Dermatitis
NCT01782729 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of A-1 Cool Cream Efficacy for Treatment Atopic Dermatitis
NCT01174511 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Behavioral Self-Help Intervention for Pediatric Atopic Dermatitis and Eczema Patients
NCT02713035 ·Status: TERMINATED ·Phase: NA
-
Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis
NCT00148746 ·Status: COMPLETED ·Phase: NA
-
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
NCT06311682 ·Status: RECRUITING ·Phase: PHASE3
-
Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children
NCT00810862 ·Status: TERMINATED ·Phase: PHASE4
-
Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of Life
NCT04900948 ·Status: COMPLETED ·Phase: PHASE4
-
Text Messaging and Atopic Dermatitis
NCT01216059 ·Status: COMPLETED ·Phase: NA
-
Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis
NCT00121381 ·Status: COMPLETED ·Phase: PHASE4
-
Use of a Mobile Health App in Managing Pediatric Atopic Dermatitis
NCT06412094 ·Status: COMPLETED ·Phase: NA
-
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
NCT03796676 ·Status: COMPLETED ·Phase: PHASE3
-
Asthma, Missed Immunizations, and Vitamin D Deficiency in Atopic Dermatitis
NCT01234909 ·Status: TERMINATED